Author guidelines for those looking to publish with FEBS Letters can be found in pdf format HERE
FEBS Letters is a world-renowned journal for rapid publication of short reports describing novel and specific biological or biochemical functions. Bringing together important developments in molecular biosciences, FEBS Letters provides an international forum for Research Letters, Reviews, Hypotheses, Commentaries and Communications. FEBS Letters articles typically report or discuss novel findings, which appeal to a broad readership, and provide molecular mechanistic insight. FEBS Letters is published by Wiley on behalf of the Federation of European Biochemical Societies(FEBS).
Papers should be short but complete and essentially final reports. The subject area of FEBS Letters is broad. Articles can be classified under the following categories: Bioenergetics; Biophysics; Cell fate determination (cell cycle, cell differentiation, cell death); Chemical Biology; Computational Biology (genomics, proteomics, bioinformatics); Cytoskeleton; Development; Enzymology; Evolution; Genome organization and stability; Glycobiology; Immunology; Membrane Biology (membrane trafficking, vesicles, organelles); Metabolism; Microbiology; Molecular basis of disease; Neuroscience; Plant Biology; Protein Chemistry; Protein Homeostasis; Redox Biology; Regulation of gene expression; RNA Biology; Signal Transduction; Structural Biology; Synthetic Biology; Systems Biology; and Virology.
As a general policy, FEBS Letters does not consider preliminary or fragmentary observations, cloning and sequencing of cDNA or genes that have previously been reported for other species, conventionally achieved expression or crystallization of proteins, description of the effect of a drug or reagent without elucidation of a detailed molecular mechanism, correlative studies or negative observations. Moreover, methodological papers are considered for publication only when they are truly novel and significant, and interesting to a broad readership.
FEBS Letters offers expedited handling of manuscripts that have been rejected with reviews from highly ranked journals. The submission should enclose reviews, comments from the editor, and the final decision letter. You will receive a decision from the handling Editor or the Editorial Office within a few days of submitting your manuscript.
The work described in your article must have been carried out in accordance with The Code of Ethics of the World Medical Association (Declaration of Helsinki) for experiments involving humans http://www.wma.net/en/30publications/10policies/b3/index.html, EU Directive 2010/63/EU for animal experiments http://ec.europa.eu/environment/chemicals/lab_animals/legislation_en.htm , Uniform Requirements for manuscripts submitted to Biomedical journals http://www.icmje.org. This must be stated at an appropriate point in the article.
FEBS Letters adheres to international standards of ethics in publishing. Data manipulation, inappropriate image processing, plagiarism, and any sort of scientific fraud are not tolerated and will be investigated. The journal will take action where misconduct is suspected, along the lines of the general principles outlined in Guidelines on Good Publication Practice, produced by the Committee on Publication Ethics (COPE). The Guidelines are available from the COPE website (www.publicationethics.org).
All authors are requested to disclose any actual or potential conflict of interest including any financial, personal or other relationships with other people or organizations within three years of beginning the submitted work that could inappropriately influence, or be perceived to influence, their work.
Submission of an article implies that the work described has not been published previously (except in the form of an abstract or as part of a published lecture or academic thesis), that it is not under consideration for publication elsewhere, that its publication is approved by all authors and tacitly or explicitly by the responsible authorities where the work was carried out, and that, if accepted, it will not be published elsewhere in the same form, in English or in any other language, including electronically without the written consent of the copyright holder. To verify originality, articles are routinely checked by the originality detection software iThenticate.
All authors should have made substantial contributions to all of the following: (1) the conception and design of the study, or acquisition of data, or analysis and interpretation of data, (2) drafting the article or revising it critically for important intellectual content, (3) final approval of the version to be submitted.
Detailed information about the specific contributions of every author should be provided. Please list all authors with their initials.
Example of Author Contributions statement:
AB and DJ conceived and supervised the study; AB and KL designed experiments; KL, DG and DGN performed experiments; AG provided new tools and reagents; KG developed new software and performed simulation studies; KL and DGN analysed data; KL, AB and DJ wrote the manuscript; KL and AB made manuscript revisions.
You are requested to identify who provided financial support for the conduct of the research and/or preparation of the article and to briefly describe the role of the sponsor(s), if any, in study design; in the collection, analysis and interpretation of data; in the writing of the report; and in the decision to submit the article for publication. If the funding source(s) had no such involvement then this should be stated.
FEBS Letters follows a subscription-based model with a delayed and hybrid open access policy. All articles are made available to non-subscribers for free after 12 months, with Review articles being available for free immediately. Additionally, FEBS Letters offers authors the option to sponsor non-subscriber access to their articles on Wiley Online Library. Authors can only select this option after receiving notification that their article has been accepted for publication. This prevents a potential conflict of interest where FEBS Letters would have a financial incentive to accept an article.
The author charge for article sponsorship is 2,200 USD. This charge is necessary to offset publishing costs: from managing article submission and peer review, to typesetting, tagging and indexing of articles, hosting articles on dedicated servers, supporting sales and marketing costs to ensure global dissemination via Wiley Online Library, and permanently preserving the published journal article. See more on open access and OnlineOpen below.
FEBS Letters complies with all funder open access requirements - including those of the Wellcome Trust, the Research Councils UK and the NIH. Please see here for our funding policy finder.
Manuscript preparation is crucial for the success of your article. Along with evaluating the novelty and technical quality of your results, the editor and reviewers judge your manuscript based on language, overall clarity and intelligibility. Poorly and sloppily written articles, as well as spelling and grammatical mistakes, may ultimately lead to the rejection of your article, even though the scientific quality would warrant publication. It is important that the files are saved in the native format of the word processor used. Keep the layout of the text as simple as possible. To avoid unnecessary errors you are strongly advised to use the 'spell-check' and 'grammar-check' functions of your word processor.
Research Letters are short articles reporting primary research. They should be self-explanatory and conclusive. Please refer to “Article Structure” for guidelines on how to write a Research Letter.
Reviews should be topical and of interest not only to specialists in the field but also to the general reader. Reviews do not have a word limit. We encourage authors to cite all primary literature in the review, as there is no limit to the references either. Prior to submitting a Review, authors should contact the Editorial Office at firstname.lastname@example.org, providing a title, abstract and key references of the article to be considered.
Hypotheses should present novel ideas or new interpretations of established observations, but should be based on sound, novel data and avoid excessive speculation. Hypotheses must be of general interest. Prior to submitting a Hypothesis, authors should contact the Editorial Office at email@example.com, providing a title, abstract and key references of the article to be considered..
Communications are short, peer-reviewed articles that expand or comment on previously published papers. Communications should contain new experimental data that provide a novel perspective to previously published results, possibly indicating caveats and discrepancies, or offering alternative interpretations. Prior discussion with the authors of the primary publication would be desirable. The results of such a correspondence may be included to the submission in the cover letter.
Commentaries are invited contributions that discuss and contextualise recently published research.
Submission to this journal proceeds totally online and you will be guided stepwise through the creation and uploading of your files. The system automatically converts your files to a single PDF file, which is used in the peer-review process.
There are no strict formatting requirements but all manuscripts must contain the essential elements needed to convey your manuscript, for example Title, Author names and affiliations, Abstract, Keywords, Introduction, Materials and Methods, Results, Conclusions, Figures and Tables with Captions. If your article includes any Videos and/or other Supplementary material, this should be included in your initial submission for peer review purposes. Please note that the Cover Letter should be uploaded separately. Your article may qualify for Fast-Track handling. Find out more in the Fast-Track Publication section.
When submitting a revision, authors are asked to upload the revised manuscript text, tables and figures, each as independent source files. Ideally, the figures should be uploaded as separate print-quality files in PDF, TIFF or EPS format. A point-by-point response to the Reviewers’ comments must be uploaded online.
The title should be a maximum of 150 characters (including spaces). FEBS Letters reserves the right to edit titles for length and clarity.
Author names and affiliations
The full names and affiliations should be provided for all authors. The corresponding author should also provide a full postal address, telephone and fax number (including country code), and an e-mail address.
The abstract should be a maximum of 120 words (180 for reviews). The abstract should state the purpose of the research, the principal results and major conclusions. Avoid non-standard or uncommon abbreviations and formulae where possible. FEBS Letters reserves the right to edit abstracts for length and clarity.
The keywords should reflect the significant factors of the investigation as a whole. A maximum of six keywords should be included.
Define non-standard or uncommon abbreviations.
The length of the submitted manuscript should not exceed 4000 words, excluding figure legends, tables, and references. Editors will accept longer papers only when there are compelling reasons to do so. Ideally, the manuscript text should be divided in the following sections:
Materials and Methods
The number and length of references is not limited. FEBS Letters strongly encourages citation of primary literature in favour of reviews where appropriate.
FEBS Letters uses a numbered system for references.There are no strict requirements on reference formatting. References can be in any style or format as long as the style is consistent. Author(s) name(s), journal title / book title, article title, year of publication, volume & issue / book chapter and the pagination must be present. The reference style required by the journal will be applied to the published version by Wiley.
Unpublished results and personal communications are not recommended in the reference list, but may be mentioned in the text. Citation of a reference as 'in press' implies that the item has been accepted for publication.
Please make sure that figure files are in an acceptable format (TIFF, EPS, PDF or MS Office files) and that the resolution is at least 300dpi and figure size 10x10cm. TIFF files may be saved with using LZW compression. Figure manipulation should be reduced to the minimum, in keeping with the following requirements:
- No specific feature within an image may be selectively enhanced, obscured, moved, removed, or introduced.
- The grouping of images from different parts of the same gel, or from different gels, fields, or exposures, must be explicitly labelled both on the figure (i.e., using dividing lines) and in the text of the figure legend. Controls must be on the same blot/gel.
- Adjustments of brightness, contrast, or colour balance are acceptable if they are applied to every pixel in the image and as long as they do not obscure, eliminate, or misrepresent any information present in the original, including the background.
- In protein or nucleic acid blots or gels the background should be visible but not oversaturated.
- In fluorescence images the manipulation of single channels is not allowed.
All digital images in manuscripts accepted for publication will be scrutinized by our figure checking service for any indication of manipulation that is inconsistent with the above guidelines. Manipulation that violates these guidelines may result in production delays or revocation of acceptance. The editors reserve the right to request original data from authors at any stage in the publication process, including post-publication.
For further information on the preparation of artwork, please see http://authorservices.wiley.com/electronicartworkguidelines.pdf.
Number tables consecutively in accordance with their appearance in the text. Place footnotes to tables below the table body and indicate them with superscript lowercase letters. Tables may be included in the manuscript file upon initial submission.
Supporting data for an article appears in the Supporting information section of an article on the journal website; it is accessible via a hyperlink and can be downloaded separately.
Supporting information is peer-reviewed material directly relevant but not essential to the conclusion of an article, such as control experiments, supporting data tables or movies. The article must be complete and self-explanatory without this additional information. It is not edited. So before submission, consider carefully how any additional data supports the paper.
File sizes must be as small as possible, so that they can be downloaded quickly, so please submit supporting information as PDFs where possible. When not possible, accepted formats are
- HTML files (.html),
- movie files (.mov/.mpg), and
- audio files (.wav/.mp3/.wma).
- Make sure you use uniform lettering and sizing of your original artwork.
- Preferred fonts: Arial (or Helvetica), Times New Roman (or Times), Symbol, Courier.
- Number the illustrations according to their sequence in the text.
- Use a logical naming convention for your artwork files.
- Indicate per figure if it is a single, 1.5 or 2-column fitting image.
- For Word submissions only, you may still provide figures and their captions, and tables within a single file at the revision stage.
- Please note that individual figure files larger than 10 MB must be provided in separate source files
A detailed guide on electronic artwork is available on our website:
Formats Regardless of the application used, when your electronic artwork is finalised, please 'save as' or convert the images to one of the following formats (note the resolution requirements for line drawings, halftones, and line/halftone combinations given below): EPS: Vector drawings. Embed the font or save the text as 'graphics'. TIFF: Color or grayscale photographs (halftones): always use a minimum of 300 dpi. TIFF: Bitmapped line drawings: use a minimum of 1000 dpi. TIFF: Combinations bitmapped line/half-tone (color or grayscale): a minimum of 500 dpi is required. If your electronic artwork is created in a Microsoft Office application (Word, PowerPoint, Excel) then please supply 'as is'. Please do not:
- Supply files that are optimised for screen use (e.g., GIF, BMP, PICT, WPG); the resolution is too low;
- Supply files that are too low in resolution;
- Submit graphics that are disproportionately large for the content.
FEBS Letters aims at connecting online articles with external databases, which are useful in their respective research communities. In accordance with the journal’s policy to make published data easily accessible and freely available, FEBS Letters requires authors to deposit large datasets such as sequences, structural data or computational models in relevant public databases. If your article contains unique identifiers or accession numbers linking to information on entities (genes, proteins, diseases, etc.) or structures deposited in public databases, then please indicate those entities according to the standards for the respective identifiers. Please use the following format: Database ID: xxx.Database linking and Accession numbersDatabase linking and Accession numbers
FEBS Letters encourages authors to share the data behind the results in their paper.
In accordance with our Database linking and Accession numbers guidelines, authors must deposit all ‘structured’ data sets (e.g. gene sequences, protein structures, microarray data, etc.) in the appropriate public databases and include the accession number in their paper.
However, we recognize that authors might also wish to share the raw data underlying other figures and tables included in their paper. To facilitate data sharing, Wiley have partnered with the figshare repository. Authors may upload ‘Data Files’ as part of the submission process. Data Files will be available to the editors and reviewers, but will not be formally peer reviewed. Upon acceptance of an article, the Data Files will be deposited free of charge to figshare on the author’s behalf, with a CC0 license (no rights reserved) applied. The data will be assigned a single DOI, which will be added to a Data Accessibility section in the article. The data on figshare will be linked back to the original article in FEBS Letters.
VERY IMPORANT: Data Files provided to figshare must not duplicate existing figures, tables or movies in the main text or supplementary information. Figshare is intended as a repository ONLY for those data that would otherwise not be included in the manuscript (e.g. raw data underlying graphs, uncropped western blots, experimental replicates, etc.). Please continue to include as supplementary information any files that are essential to the full understanding of your paper.
Authors must not submit data that is sensitive in nature or should not be made publicly available due to privacy, security, and/or safety concerns, such as human subject data or the location of endangered species.
Further information about this data sharing service is available here http://olabout.wiley.com/WileyCDA/Section/id-828082.html. Please feel free to contact the editorial office at firstname.lastname@example.org if you have additional questions.
Authors should comply with available field-specific standards for the preparation and recording of data. We recommend you to refer to the Minimum Information for Biological and Biomedical Investigations (MIBBI) Portal for prescriptive checklists for reporting biological and biomedical research where applicable: http://mibbi.sourceforge.net/.
Please submit the names, addresses and e-mail addresses of potential reviewers. You can also specify whom you would like to exclude from reviewing the manuscript. Note that the Editor retains the sole right to decide whether the suggested and excluded reviewers are used or not.
All papers must be in English. Non-English speaking authors who do not have a good command of English are advised to seek assistance from someone who has.
Authors for whom English is a second language may choose to have their manuscript professionally edited before submission to improve the English language. A list of independent suppliers of editing services can be found at http://wileyeditingservices.com/en/. Japanese authors can also find a list of local English improvement services at http://www.wiley.co.jp/journals/editcontribute.html. All services are paid for and arranged by the author, and use of one of these services does not guarantee acceptance or preference for publication.
Submission to FEBS Letters proceeds online at https://mc.manuscriptcentral.com/febsl. You may choose to submit your manuscript as a single file to be used in the initial peer-review process. For details see the section on New Submissions. The system automatically converts your files to a single PDF file.
Upon submitting your revision you are requested to upload the source files of the manuscript, tables, figures and supplementary data separately. Point-by-point responses to the original reviewers' comments should be uploaded online.
For questions on the submission process, please contact the Editorial Office prior to submission at email@example.com. All correspondence, including notification of the Editor's decision and requests for revision, takes place by e-mail. For general information about publishing with Wiley see: http://exchanges.wiley.com/authors/authors_268.html
If your paper is accepted, the author identified as the formal corresponding author for the paper will receive an email prompting them to login into Author Services; where via the Wiley Author Licensing Service (WALS) they will be able to complete the license agreement on behalf of all authors on the paper.
For authors signing the copyright transfer agreement
If the OnlineOpen option is not selected the corresponding author will be presented with the copyright transfer agreement (CTA) to sign. The terms and conditions of the CTA can be previewed in the samples associated with the Copyright FAQs below:
CTA Terms and Conditions http://exchanges.wiley.com/authors/faqs---copyright-_301.html.
For authors choosing OnlineOpen
If the OnlineOpen option is selected the corresponding author will have a choice of the following Creative Commons License Open Access Agreements (OAA):
Creative Commons Attribution License OAA
Creative Commons Attribution Non-Commercial License OAA
Creative Commons Attribution Non-Commercial -NoDerivs License OAA
To preview the terms and conditions of these open access agreements please visit the Copyright FAQs hosted on Wiley Author Services http://exchanges.wiley.com/authors/faqs---copyright-_301.html and visit http://www.wileyopenaccess.com/details/content/12f25db4c87/Copyright--License.html .
If you select the OnlineOpen option and your research is funded by certain funders [e.g. The Wellcome Trust and members of the Research Councils UK (RCUK) or the Austrian Science Fund (FWF)] you will be given the opportunity to publish your article under a CC-BY license supporting you in complying with Wellcome Trust and Research Councils UK requirements. For more information on this policy and the Journal’s compliant self-archiving policy please visit: http://www.wiley.com/go/funderstatement.
Authors or a third party wishing to reproduce figures, tables or brief quotations from the text of articles published in FEBS Letters for non-commercial purposes may do so, providing the original publication is acknowledged accordingly and the authors' approval is obtained. No special permission is needed from FEBS or Wiley. If authors or a third party wish to use a major part of an article or an entire article elsewhere, whether in English or any translation, permission must be asked from Wiley, who will if necessary contact FEBS, the copyright holder.
FEBS Letters provides authors with Wiley-Blackwell's Accepted Articles service, whereby peer reviewed, accepted articles, are published online within days of acceptance, without having been copyedited or typeset. The articles are available as a PDF and can be cited using their Digital Object Identifier (DOI) numbers. For more information on DOIs, please see http://www.doi.org.faq.html. Please note, as Accepted Articles are not considered to be final, changes may be made after the Accepted Article online publication date. Once copyedited and typeset, the article will be removed from the Accepted Articles area and will appear instead in Early View.
The implementation of the Accepted Articles service has been designed to ensure the earliest possible circulation of research papers immediately after acceptance, considerably reducing time to publication.
Page proofs will be sent electronically to the corresponding author, who will receive an e-mail alert containing a link to a secure web site for the proofs. A working e-mail address must therefore be provided for the corresponding author. In the absence of the corresponding author, please arrange for a colleague to access the e-mail to retrieve the proofs. Please note that you (ie ALL authors) have final responsibility for what is stated in the proofs of your manuscript.
Significant changes to the article as accepted for publication will only be considered at this stage with permission from the Editorial Office. Note that Wiley may proceed with the publication of your article if no response is received within 48 hours.
FEBS Letters uses Wiley-Blackwell's Early View service. Early View articles are complete and final full-text articles published online in advance of their publication in a printed issue. They are fully copyedited and typeset and therefore no changes can be made after an article is published in Early View. The nature of Early View articles means that they do not yet have volume, issue or page numbers. They can be referenced and tracked before being allocated to an issue by using the Digital Object Identifier (DOI). This will be the same DOI as assigned at Accepted Article stage. After print publication, the DOI remains valid and can continue to be used to cite and access the article. For more information on DOIs, please see http://www.doi.org.faq.html.
FEBS Letters has no page charges.
Free access to the final PDF of the article will be available via Author Services only. Reprints can be purchased at current printing prices.
Requests to add or remove an author, or to rearrange the author names, must be sent to the Editorial Office and must include: (a) the reason the name should be added or removed, or the author names rearranged and (b) written confirmation (e-mail, fax, letter) from all authors that they agree with the addition, removal or rearrangement. In the case of addition or removal of authors, this includes confirmation from the author being added or removed. Any requests to add, delete, or rearrange author names in an already published article will follow the same policies as noted above and result in a corrigendum.
For questions on the submission or reviewing process, please contact the Editorial Office at firstname.lastname@example.org. Contact details for questions arising after acceptance of an article, especially those relating to proofs, will be provided by the publisher.
Wiley's Author Services platform allows authors to track the production status of their article, opt in to OnlineOpen, and gain free access to their final published article and share the free access with up to 10 colleagues.
You can also check Wiley's Author FAQs ( http://exchanges.wiley.com/authors/help_756.html).
- The 2016 FEBS Letters Crossword Challenge now solved!
Please click on the link above to access The FEBS Letters Crossword with clues based on the 2016 Editors’ Choices, and scroll down for the solutions.
- We congratulate FEBS Letters author Prof. Yoshinori Ohsumi on winning the 2016 Nobel Prize in Physiology or Medicine
- Read the celebratory FEBS Letters Virtual Issue "Autophagy: The 2016 Nobel Prize" collecting elegant studies on autophagy performed by Yoshinori Ohsumi and his coworkers